Skip to main content

Brian Ward, Stella Quan, Stefan Mllner, Christoph Hls

The DNA Repair Company has appointed Brian Ward as executive vice president and named Stella Quan senior director of product development.
Ward formerly was senior VP for Genomic Health. He also has served as president of medical genetic services and senior vice president of operations at Myriad Genetic Laboratories, and he has worked at Genzyme Genetics and at the University of Colorado.
Quan was director of immunoassay development for bioMérieux, was senior director of operations at Tripath Oncology, and was involved in research and development at Chiron.

Stefan Müllner has been named the new CEO of Protagen, succeeding Christoph Hüls, who is leaving the firm to join an unnamed pharmaceutical company. Müllner has been the firm's chief scientific officer.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.